129 related articles for article (PubMed ID: 1805729)
1. Influence of iron chelators, 1,2-dialkyl-3-hydroxypyridin-4-ones, on the lipid peroxidation and glutathione level in the liver of mice.
Eybl V; Caisová D; Koutenský J; Kontoghiorghes GJ
Arch Toxicol Suppl; 1991; 14():185-7. PubMed ID: 1805729
[No Abstract] [Full Text] [Related]
2. Antioxidant and free radical scavenging activities of the iron chelators pyoverdin and hydroxypyrid-4-ones in iron-loaded hepatocyte cultures: comparison of their mechanism of protection with that of desferrioxamine.
Morel I; Cillard J; Lescoat G; Sergent O; Pasdeloup N; Ocaktan AZ; Abdallah MA; Brissot P; Cillard P
Free Radic Biol Med; 1992 Nov; 13(5):499-508. PubMed ID: 1334028
[TBL] [Abstract][Full Text] [Related]
3. The influence of deferiprone (L1) and deferoxamine on iron and essential element tissue level and parameters of oxidative status in dietary iron-loaded mice.
Eybl V; Kotyzová D; Kolek M; Koutenský J; Nielsen P
Toxicol Lett; 2002 Mar; 128(1-3):169-75. PubMed ID: 11869827
[TBL] [Abstract][Full Text] [Related]
4. Iron mobilization from myocardial cells by 3-hydroxypyridin-4-one chelators: studies in rat heart cells in culture.
Hershko C; Link G; Pinson A; Peter HH; Dobbin P; Hider RC
Blood; 1991 May; 77(9):2049-53. PubMed ID: 2018841
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of iron toxicity in rat and human hepatocyte cultures by the hydroxypyridin-4-ones CP20 and CP94.
Chenoufi N; Hubert N; Loréal O; Morel I; Pasdeloup N; Cillard J; Brissot P; Lescoat G
J Hepatol; 1995 Aug; 23(2):166-73. PubMed ID: 7499788
[TBL] [Abstract][Full Text] [Related]
6. Origin and fate of iron mobilized by the 3-hydroxypyridin-4-one oral chelators: studies in hypertransfused rats by selective radioiron probes of reticuloendothelial and hepatocellular iron stores.
Zevin S; Link G; Grady RW; Hider RC; Peter HH; Hershko C
Blood; 1992 Jan; 79(1):248-53. PubMed ID: 1728313
[TBL] [Abstract][Full Text] [Related]
7. Glutathione depletion increases nitric oxide-induced oxidative stress in primary rat hepatocyte cultures: involvement of low-molecular-weight iron.
Sinbandhit-Tricot S; Cillard J; Chevanne M; Morel I; Cillard P; Sergent O
Free Radic Biol Med; 2003 May; 34(10):1283-94. PubMed ID: 12726916
[TBL] [Abstract][Full Text] [Related]
8. The iron chelator deferoxamine prevents cisplatin-induced lipid peroxidation in rat kidney cortical slices.
Kameyama Y; Gemba M
Jpn J Pharmacol; 1991 Oct; 57(2):259-62. PubMed ID: 1812305
[TBL] [Abstract][Full Text] [Related]
9. The oral iron chelator, 1,2-dimethyl-3-hydroxypyrid-4-one reduces hepatic-free iron, lipid peroxidation and fat accumulation in chronically ethanol-fed rats.
Sadrzadeh SM; Nanji AA; Price PL
J Pharmacol Exp Ther; 1994 May; 269(2):632-6. PubMed ID: 8182529
[TBL] [Abstract][Full Text] [Related]
10. EPR study of antioxidant activity of the iron chelators pyoverdin and hydroxypyrid-4-one in iron-loaded hepatocyte culture: comparison with that of desferrioxamine.
Morel I; Sergent O; Cogrel P; Lescoat G; Pasdeloup N; Brissot P; Cillard P; Cillard J
Free Radic Biol Med; 1995 Feb; 18(2):303-10. PubMed ID: 7744315
[TBL] [Abstract][Full Text] [Related]
11. Green tea extract modulates oxidative tissue injury in beta-thalassemic mice by chelation of redox iron and inhibition of lipid peroxidation.
Koonyosying P; Kongkarnka S; Uthaipibull C; Svasti S; Fucharoen S; Srichairatanakool S
Biomed Pharmacother; 2018 Dec; 108():1694-1702. PubMed ID: 30372872
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and evaluation of N-basic substituted 3-hydroxypyridin-4-ones: orally active iron chelators with lysosomotrophic potential.
Liu ZD; Khodr HH; Lu SL; Hider RC
J Pharm Pharmacol; 2000 Mar; 52(3):263-72. PubMed ID: 10757413
[TBL] [Abstract][Full Text] [Related]
13. The effect of iron(III) on the activity of selenoenzymes and oxidative damage in the liver of rats. Interaction with natural antioxidants and deferiprone.
Hodková A; Cerná P; Kotyzová D; Eybl V
Hemoglobin; 2010 Jun; 34(3):278-83. PubMed ID: 20524817
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of the protective effect between deferoxamine and deferiprone on chronic iron overload induced cardiotoxicity in rats.
Emara AM; El Kelany RS; Moustafa KA
Hum Exp Toxicol; 2006 Jul; 25(7):375-85. PubMed ID: 16898166
[TBL] [Abstract][Full Text] [Related]
15. Effects of green tea on iron accumulation and oxidative stress in livers of iron-challenged thalassemic mice.
Saewong T; Ounjaijean S; Mundee Y; Pattanapanyasat K; Fucharoen S; Porter JB; Srichairatanakool S
Med Chem; 2010 Mar; 6(2):57-64. PubMed ID: 20218965
[TBL] [Abstract][Full Text] [Related]
16. Effect of oral iron chelator L1 on iron absorption in man.
Dresow B; Fischer R; Nielsen P; Gabbe EE; Piga A
Ann N Y Acad Sci; 1998 Jun; 850():466-8. PubMed ID: 9668586
[No Abstract] [Full Text] [Related]
17. Antimalarial effect of iron chelators.
Gordeuk VR; Loyevsky M
Adv Exp Med Biol; 2002; 509():251-72. PubMed ID: 12572998
[No Abstract] [Full Text] [Related]
18. Effect of novel 1-alkyl-3-hydroxy-2-methylpyrid-4-one chelators on uptake and release of iron from macrophages.
Brock JH; Licéaga J; Arthur HM; Kontoghiorghes GJ
Am J Hematol; 1990 May; 34(1):21-5. PubMed ID: 2327400
[TBL] [Abstract][Full Text] [Related]
19. The development of hydroxypyridin-4-ones as orally active iron chelators.
Hider RC; Singh S; Porter JB; Huehns ER
Ann N Y Acad Sci; 1990; 612():327-38. PubMed ID: 2291561
[No Abstract] [Full Text] [Related]
20. Iron chelation studies using desferrioxamine and the potential oral chelator, 1,2-dimethyl-3-hydroxypyrid-4-one, in normal and iron loaded rats.
Kontoghiorghes GJ; Sheppard L; Hoffbrand AV; Charalambous J; Tikerpae J; Pippard MJ
J Clin Pathol; 1987 Apr; 40(4):404-8. PubMed ID: 3584483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
